comparemela.com

Latest Breaking News On - Cell adherent technology - Page 1 : comparemela.com

Sirolimus-eluting balloon successfully treats long lesions in patients with CLI

Sirolimus-eluting balloon successfully treats long lesions in patients with CLI
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

MedAlliance Acquired by Cordis for up to USD 1 135 Billion - PRN India News

MedAlliance Acquired by Cordis for up to USD 1 135 Billion - PRN India News
webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.

MedAlliance Acquired by Cordis for USD 1 135 Billion - Thailand Business News

MedAlliance Acquired by Cordis for USD 1 135 Billion - Thailand Business News
thailand-business-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thailand-business-news.com Daily Mail and Mail on Sunday newspapers.

MedAlliance Acquired by Cordis for up to USD 1 135 Billion

MedAlliance Acquired by Cordis for up to USD 1 135 Billion
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Business News | MedAlliance Acquired by Cordis for Up to USD 1 135 Billion

Get latest articles and stories on Business at LatestLY. Geneva [Switzerland], October 2: Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of USD 35M and a 2023 upfront closing payment of USD 200M, together with regulatory achievement milestones of up to USD 125M and commercial milestones of up to USD 775M through 2029, for a total consideration of up to USD 1.135 Billion.  Business News | MedAlliance Acquired by Cordis for Up to USD 1.135 Billion.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.